Scaling in America

Together with our provider Wilson Sonsini, we look to offer a wealth of information and support to non-U.S. companies that have decided to enter the U.S. market – whether to expand, raise investment capital, or pursue key transactions. This session on “Scaling in America” will assist UK and European technology and life sciences companies tackling the challenges of U.S. expansion and raising capital in the world’s largest and most competitive economy.

• Date: 10 March 2022
• Time: 3:00 GMT

Members of Wilson Sonsini’s U.S. Expansion team will discuss two important factors related to scaling a company in the United States: how to best plan for expansion and what you need to know before embarking on a fundraising journey in the U.S. market.

Several frequently asked questions will be addressed:

•           When should I consider establishing U.S. operations?

•           When should I look to raise money from U.S. VCs?

•           Do I need a U.S. company to raise money from U.S. VCs?

•           When do I need to create a U.S. company?

•           How long does U.S. set-up take and how much does it cost?

•           How do I sell/pitch in the U.S. as a non-U.S. founder?

•           Are there U.S. government resources to assist with U.S. expansion?

Speakers 

• Daniel Glazer – Managing Partner, Wilson Sonsini London Office
• Matthew Meyer – Chief Business Advisor, Life Sciences Business Advisory, Wilson Sonsini San Francisco Office

Join us 

Don’t miss the chance to hear from experts and leaders from the Life Sciences and Technology Sector. To register, please click the button.

Supported by

To find out more, or if you have any questions please contact Katarzyna Chys